Targeting RUNX1 as a novel treatment modality for pulmonary arterial hypertension is a research paper published in Cardiovascular Research (2022). On theSindex it has a DataRank of 0. It has been cited 42 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P20 GM119943 (O.D.L. and P.J.Q.), P20 GM103652 (O.D.L.), R01 HL141268 (C.E.V.), and T32 HL116249 (E.-Y.S., O.D.L., and P.J.Q.)
American Heart Association Transformational Project Award
Grant: 18TPA34110329 (O.D.L.)
Rhode Island Foundation Medical Research Fund
Grant: Nr. 5219_20200595 (E.-M.J. and O.D.L.)
NIGMS NIH HHS
Grant: P20 GM103652
NCI NIH HHS
Grant: R01 CA218079
NHLBI NIH HHS
Grant: R01 HL141268
NCRR NIH HHS
Grant: P20 RR025179
NIGMS NIH HHS
Grant: P20 GM119943
NHLBI NIH HHS
Grant: T32 HL116249
National Institutes of Health
Grant: 5P20GM119943-03
Stem Cells and Aging
National Institutes of Health
Grant: 5R01HL141268-05
Effects of DHEA in Pulmonary Hypertension (DiPH)
National Institutes of Health
Grant: 4T32HL116249-04
Hematology Post Doctoral Training
National Institutes of Health
Grant: 1P20GM103652-01A1
Sex Hormones and Pulmonary Vascular and Right Ventricular Dysfunction
Academic Assessment Research Award from the Brown Physicians, Inc.
FWCI
4.77
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Replication Data for Targeting RUNX1 as a novel treatment modality for pulmonary arterial hypertension